Back

Prognostic implications of microvascular resistance reserve in symptomatic patients with intermediate coronary stenosis

1 September 2024 (13:35 - 13:45)
Organised by: Logo
Congress Presentation Part of: Functional testing in coronary artery disease Coronary Microcirculation and Collaterals ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Joo Myung Lee

Samsung Medical Center, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Clinical value of single projection angiography-derived FFR in non-infarct related artery
Assistant Professor S. Lee (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
Influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of percutaneous coronary intervention
Doctor D. Munhoz (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
VERMONT non-optimised: can baseline diagnostic catheter images be used to measure angiography based CAAS-vFFR?
Doctor D. Akrawi (London, GB)
Abstract Slides Video
Presentation thumbnail
Fractional flow reserve versus solely angiography-guided revascularisation in coronary artery disease, systematic review and meta-analysis.
Mr M. Blaziak (Wroclaw, PL)
Abstract Slides Video
Presentation thumbnail
Antiplatelet agents in patients with intermediate coronary artery stenosis and deferred revascularization
Doctor D. Hong (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Functional testing in coronary artery disease
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 13:35 CET
You may be interested in
thumbnail
Congress Presentation
Advancing prognostic insights in STEMI patients through microvascular resistance reserve evaluation
thumbnail
Congress Presentation
Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.
thumbnail
Congress Presentation
The influence of epicardial resistance on Microvascular Resistance Reserve (MRR)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources